264 related articles for article (PubMed ID: 32894225)
1. Sox17 and β-catenin co-occupy Wnt-responsive enhancers to govern the endoderm gene regulatory network.
Mukherjee S; Chaturvedi P; Rankin SA; Fish MB; Wlizla M; Paraiso KD; MacDonald M; Chen X; Weirauch MT; Blitz IL; Cho KW; Zorn AM
Elife; 2020 Sep; 9():. PubMed ID: 32894225
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse.
Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H
Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574
[TBL] [Abstract][Full Text] [Related]
3. SOX transcription factors direct TCF-independent WNT/β-catenin responsive transcription to govern cell fate in human pluripotent stem cells.
Mukherjee S; Luedeke DM; McCoy L; Iwafuchi M; Zorn AM
Cell Rep; 2022 Aug; 40(8):111247. PubMed ID: 36001974
[TBL] [Abstract][Full Text] [Related]
4. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
5. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes.
Sinner D; Rankin S; Lee M; Zorn AM
Development; 2004 Jul; 131(13):3069-80. PubMed ID: 15163629
[TBL] [Abstract][Full Text] [Related]
6. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
7. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the evolutionarily conserved cis-regulatory elements on the sox17 gene in zebrafish.
Chan TM; Chao CH; Wang HD; Yu YJ; Yuh CH
Dev Biol; 2009 Feb; 326(2):456-70. PubMed ID: 19084513
[TBL] [Abstract][Full Text] [Related]
9. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
11. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.
Chen HL; Chew LJ; Packer RJ; Gallo V
Cancer Lett; 2013 Jul; 335(2):361-71. PubMed ID: 23474492
[TBL] [Abstract][Full Text] [Related]
13. Fine-Tuning of Sox17 and Canonical Wnt Coordinates the Permeability Properties of the Blood-Brain Barrier.
Corada M; Orsenigo F; Bhat GP; Conze LL; Breviario F; Cunha SI; Claesson-Welsh L; Beznoussenko GV; Mironov AA; Bacigaluppi M; Martino G; Pitulescu ME; Adams RH; Magnusson P; Dejana E
Circ Res; 2019 Feb; 124(4):511-525. PubMed ID: 30591003
[TBL] [Abstract][Full Text] [Related]
14. A framework for the establishment of a cnidarian gene regulatory network for "endomesoderm" specification: the inputs of ß-catenin/TCF signaling.
Röttinger E; Dahlin P; Martindale MQ
PLoS Genet; 2012; 8(12):e1003164. PubMed ID: 23300467
[TBL] [Abstract][Full Text] [Related]
15. SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells.
Chew LJ; Shen W; Ming X; Senatorov VV; Chen HL; Cheng Y; Hong E; Knoblach S; Gallo V
J Neurosci; 2011 Sep; 31(39):13921-35. PubMed ID: 21957254
[TBL] [Abstract][Full Text] [Related]
16. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
17. SOX17 in cellular reprogramming and cancer.
Tan DS; Holzner M; Weng M; Srivastava Y; Jauch R
Semin Cancer Biol; 2020 Dec; 67(Pt 1):65-73. PubMed ID: 31419525
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-activated Ndrg1a represses Wnt/β-catenin signaling to allow Xenopus pancreas, oesophagus, stomach, and duodenum specification.
Zhang T; Guo X; Chen Y
PLoS One; 2013; 8(5):e65058. PubMed ID: 23741453
[TBL] [Abstract][Full Text] [Related]
19. OCT4 Coordinates with WNT Signaling to Pre-pattern Chromatin at the SOX17 Locus during Human ES Cell Differentiation into Definitive Endoderm.
Ying L; Mills JA; French DL; Gadue P
Stem Cell Reports; 2015 Oct; 5(4):490-8. PubMed ID: 26411902
[TBL] [Abstract][Full Text] [Related]
20. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
